Searched for
GLENMARK PROFIT
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Glenmark closes 3% lower post API arm sale dealAccording to analysts, the sale of Glenmark Life could impact the profitability of Glenmark Pharma in FY25 but lower interest payments coul...
- Glenmark Pharma Q4 Results: Profit declines 12.3% on higher input costs and lower demandGlenmark Pharmaceuticals' Q4 consolidated profit before exceptional items and tax was INR3.09bn ($37.78m) for the quarter ended 31 March, d...
- Glenmark Pharma reports 31% drop in net profit to Rs 211 croreGlenmark is ranked 14th with a market share of 2.17% Sales from North America fell 10.2% YoY to Rs 663 crore. Europe sales saw 8% YoY to Rs...
- Glenmark Pharma Q2 results: Net profit rises 17% to Rs 275 crIts consolidated revenue from operations during July-September 2021 stood at Rs 3,147.44 crore. It was Rs 2,952.47 crore for the same perio...
- Glenmark Pharma Q4 results: Net profit rises 6% to Rs 234 crIts consolidated revenue from operations stood at Rs 2,859.9 crore for the quarter under consideration. It was Rs 2,767.5 crore for the sam...
- Glenmark drops 6% as Q2 net profit declinesThe stock has nearly trebled from its March lows of Rs 168, and is up 39 per cent year-to-date.
- Glenmark Pharma jumps nearly 8% after Q2 earningsThe company had posted a net profit of Rs 414 crore in the July-September quarter a year ago.
- Glenmark Q4 net up 23.5% to Rs 184 croreConsolidated revenue from operations of the company also rose to Rs 9,185.68 crore for the financial year ended March 2017. It was Rs 7,649...
- Glenmark Pharmaceuticals reports Q4 net profit at Rs 10.61 croreGlenmark Pharmaceuticals reported a consolidated net profit of Rs 10.61 crore for the fourth quarter ended March 31, 2015.
- Glenmark Pharmaceuticals Q2 net up 6.98 per cent at Rs 165.07 croreGlenmark's net sales rose by 14.25 per cent to Rs 1,671.53 crore during the second quarter as compared with Rs 1,463 crore in the same peri...
- Glenmark Pharma Q4 net profit at Rs 43 croreConsolidated net sales of the company rose to Rs 1,681.74 crore for the fourth quarter, as against Rs 1,335.48 crore in the same period of ...
- Glenmark under pressure after losing patent battle to AbbottShares of Glenmark Pharmaceuticals saw profit booking after the company announced that it has lost appeal to invalidate Abbott's patent for...
- Glenmark Pharma hits 52-week high, analysts recommend ‘buy’The company company had posted a net profit of Rs 208.58 crore during the same period of the previous fiscal, Glenmark Pharmaceuticals said...
- Glenmark Pharma's net profit at Rs 78 crore in June quarterThe firm had posted a net profit of Rs 208.58 crore during the same period of previous fiscal, Glenmark Pharma said.
- Glenmark posts Q2 net profit of Rs 55.85 croreDrug firm Glenmark Pharmaceuticals today reported a consolidated net profit of Rs 55.85 crore for the quarter ended September 30, 2011.
- Glenmark loses patent case to Abbott over hypertension drugGlenmark has lost a patent case against US firm Abbott Laboratories over hypertension drug Tarka.
- Hold Glenmark Pharma for profits: Shardul KulkarniThis stock has achieved its price target. From a trading perspective, one should book profits.
- Glenmark Q1 jumps nearly three-fold to Rs 155 cr on good salesGlenmark Pharmaceuticals on Tuesday reported nearly three-fold jump in consolidated net profit at Rs 155.54 crore for the first quarter end...
Load More
